Latest News

Quanta News

Quanta unveils SC+ dialysis system

28th September 2017

Seroba’s investee company, Quanta Dialysis Technologies Ltd, a medical device company providing innovative haemodialysis solutions for the clinic and the home, has unveiled at the 10th UK Annual Dialysis Conference in Manchester, UK, its SC+ personal haemodialysis system for market […]

Read More
Fusion News

Seroba Invests in Fusion Pharmaceuticals

25th September 2017

Hamilton, Ontario, September 25, 2017. Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced it has completed a second closing of its Series A financing, securing an additional $21 million USD in capital and […]

Read More
Novate News

Novate Filter Yields Zero Pulmonary Embolisms at 12 Months

12th September 2017

Galway, Ireland – 12 September 2017.  Clinical trial results for Novate’s SENTRY device have been presented by Principal Investigator, Michael Dake MD of Stanford University in California at the 15th Annual Conference on Vascular Interventional Advances (VIVA17), which has been taking place […]

Read More
Pq Bypass

PQ Bypass Unveils New Data From DETOUR I at VIVA 17

12th September 2017

Seroba’s investee company, PQ Bypass, today announced data from a subset analysis of the DETOUR I clinical trial during a late-breaking clinical trial session at Vascular InterVentional Advances (VIVA 17), which is taking place September 11-14 in Las Vegas. The […]

Read More
Biomimics 3d

Mimics Study’s Outcomes Announced at VIVA17

12th September 2017

Professor Thomas Zeller MD announced new significant outcomes from the Mimics Study today at the 15th Annual Conference on Vascular Interventional Advances (VIVA17) in Las Vegas, NV, USA. The BioMimics 3D Vascular Stent with unique helical curvature to generate swirling […]

Read More
Peter Sandys

Peter Sandys is the New Chair of the IVCA

31st August 2017

Managing Partner of Seroba Life Sciences has been appointed Chairman of the Irish Venture Capital Association (IVCA). To mark the appointment, business journalist Adrian Weckler of the Irish Independent Newspaper interviewed Peter Sandys about the future of Venture Capital in […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top